HCV NS5A abrogates p53 protein function by interfering with p53-DNA binding

doi:10.3748/wjg.v10.i15.2223

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 15

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2633)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

264

HTML

1968

Figures (1-2)

213

Tables (1-3)

188

Sum=2633

Aug 1, 2004 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Aug 1, 2004; 10(15): 2223-2227
Published online Aug 1, 2004. doi: 10.3748/wjg.v10.i15.2223

Full Size Figure Download Figure

Figure 1 HCVNS5A inhibits p53 binding to its specific DNA probe. Lane 1: Negative control; Lane 2: Transfected with pC53-NS3 only; Lane 3: Transfected with pCNS5A only; Lanes 4 -6: Co-transfected with pC53-NS3 (1 μg) and different dose of pCNS5A; Lanes 7-8: Transfected with pC53-NS3, and antip53, antiNS5A anti-bodies were added to the reaction mixture individually.

Citation: Gong GZ, Jiang YF, He Y, Lai LY, Zhu YH, Su XS. HCV NS5A abrogates p53 protein function by interfering with p53-DNA binding. World J Gastroenterol 2004; 10(15): 2223-2227
URL: https://www.wjgnet.com/1007-9327/full/v10/i15/2223.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i15.2223